Contribution of markers of adiposopathy and adipose cell size in predicting insulin resistance in women of varying age and adiposity

References

• Bastien M, Poirier P, Lemieux I, et al. Overview of epidemiology and contribution of obesity to cardiovascular disease.Prog Cardiovasc Dis. 2014;Jan-Feb 56(4):369–381.
   PubMed Web of Science ®Google Scholar
• Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation. 2021 May 25 143(21):e984–e. 1010
   Google Scholar
• St-Pierre J, Lemieux I, Vohl MC, et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol.2002 Jul 1 90(1)15–18.
   PubMed Web of Science ®Google Scholar
• Piché ME, Poirier P, Lemieux I, et al. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an UPdate. Prog Cardiovasc Dis. 2018;Jul Aug 61(2):103–113.
   PubMed Web of Science ®Google Scholar
• Bays HE. Adiposopathy is “sick fat” a cardiovascular disease? J Am Coll Cardiol. 2011 Jun 21 57(25): 2461–2473.
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Poirier P, Després JP. Cardiovascular and metabolic heterogeneity of obesity. Clinical Challenges and Implications for Management. Circulation. 2018 Mar 27 137(13): 1391–1406.
   Google Scholar
• Choe SS, Huh JY, Hwang IJ, et al. Adipose Tissue remodeling: its role in energy metabolism and metabolic disorders. Front Endocrinol (Lausanne). 2016;7:30
   PubMed Web of Science ®Google Scholar
• Laforest S, Labrecque J, Michaud A, et al. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction. Crit Rev Clin Lab Sci. 2015;52(6):301–313
   PubMed Web of Science ®Google Scholar
• Veilleux A, Caron-Jobin M, Noël S, et al. Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes. 2011;May 60(5):1504–1511.
   PubMed Web of Science ®Google Scholar
• Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;Jan 93(1):359–404
   PubMed Web of Science ®Google Scholar
• Drolet R, Richard C, Sniderman AD, et al. Hypertrophy and hyperplasia of abdominal adipose tissues in women.Int J Obes (Lond). 2008;Feb 32(2):283–291.
   PubMed Web of Science ®Google Scholar
• Reilly SM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol. 2017;Nov 13(11):633–643
   PubMed Web of Science ®Google Scholar
• Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity.Am J Physiol Cell Physiol. 2021 Mar 1 320(3):C375–C391
   PubMed Web of Science ®Google Scholar
• Thomas D, Apovian C. Macrophage functions in lean and obese adipose tissue. Metabolism. 2017;Jul 72 120–143.
   PubMed Web of Science ®Google Scholar
• Engin AB. Adipocyte-Macrophage cross-talk in obesity. Adv Exp Med Biol. 2017;960 327–343.
   PubMed Web of Science ®Google Scholar
• Michaud A, Drolet R, Noël S, et al. Visceral fat accumulation is an indicator of adipose tissue macrophage infiltration in women. Metabolism. 2012;May 61(5):689–698.
   PubMed Web of Science ®Google Scholar
• Michaud A, Pelletier M, Noël S, et al. Markers of macrophage infiltration and measures of lipolysis in human abdominal adipose tissues. Obesity. Silver Spring 2013;Nov 21(11):2342–2349.
   PubMed Web of Science ®Google Scholar
• Bays HE, Gonzalez-Campoy JM, Henry RR, et al. Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract. 2008;Oct 62(10):1474–1483.
   PubMed Web of Science ®Google Scholar
• Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010 Mar 25 316(2): 129–139.
   PubMed Web of Science ®Google Scholar
• Robinson K, Prins J, Venkatesh B. Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit Care. 2011 Apr 20 15(2): 221.
   PubMed Web of Science ®Google Scholar
• Friedman J. 20 years of leptin: leptin at 20: an overview. J Endocrinol. 2014;‘Oct 223(1):T1–8.
   PubMed Web of Science ®Google Scholar
• Frühbeck G, Catalan V, Rodriguez A, et al. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation. Nutrients. 2019 Feb 22 11(2):454.
   Web of Science ®Google Scholar
• Frühbeck G, Catalan V, Rodriguez A, et al. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte.2018 Jan 2 7(1)57–62.
   PubMed Web of Science ®Google Scholar
• Vega GL, Grundy SM. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. J Obes. 2013;2013 409679.
   PubMedGoogle Scholar
• Inoue M, Maehata E, Yano M, et al. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism. 2005;Mar 54(3):281–286.
   PubMed Web of Science ®Google Scholar
• Clément AA, Riesco E, Tessier S, et al. The relationship between adiposopathy and glucose-insulin homeostasis is not affected by moderate-intensity aerobic training in healthy women with obesity. J Physiol Biochem. 2018;Nov 74(4):591–601.
   PubMed Web of Science ®Google Scholar
• Inoue M, Yano M, Yamakado M, et al. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism. 2006;Sep 55(9):1248–1254.
   PubMed Web of Science ®Google Scholar
• Huth C, Pigeon E, Riou ME, et al. Fitness, adiposopathy, and adiposity are independent predictors of insulin sensitivity in middle-aged men without diabetes. J Physiol Biochem. 2016;Sep 72(3):435–444.
   PubMed Web of Science ®Google Scholar
• Unamuno X, Izaguirre M, Gomez-Ambrosi J, et al. Increase of the adiponectin/leptin ratio in patients with obesity and type 2 diabetes after roux-en-y gastric bypass. Nutrients. 2019 Sep 3 11(9): 2069.
   PubMed Web of Science ®Google Scholar
• Harman-Boehm I, Bluher M, Redel H, et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab. 2007;Jun 92(6):2240–2247.
   PubMed Web of Science ®Google Scholar
• Arner E, Westermark PO, Spalding KL, et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes. 2010;Jan 59(1):105–109.
   PubMed Web of Science ®Google Scholar
• Ryden M, Andersson DP, Bergstrom IB, et al. Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study. J Clin Endocrinol Metab. 2014;Oct 99(10):E1870–6.
   PubMed Web of Science ®Google Scholar
• Michaud A, Laforest S, Pelletier M, et al. Abdominal adipocyte populations in women with visceral obesity. Eur J Endocrinol. 2016;Feb 174(2):227–239.
   PubMed Web of Science ®Google Scholar
• Lundgren M, Svensson M, Lindmark S, et al. Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’. Diabetologia. 2007;Mar 50(3):625–633.
   PubMed Web of Science ®Google Scholar
• Fang L, Guo F, Zhou L, et al. The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans. Adipocyte. 2015;Oct-Dec 4(4):273–279.
   PubMed Web of Science ®Google Scholar
• Mauriège P, Karelis AD, Taleb N, et al. Comparing an adiposopathy approach with four popular classifications schemes to categorize the metabolic profile of postmenopausal women. J Physiol Biochem. 2020;Nov 76(4):609–622.
   PubMed Web of Science ®Google Scholar
• Lemieux I, Poirier P, Bergeron J, et al. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol. 2007;Oct 23 23B–31B.
   PubMed Web of Science ®Google Scholar
• Fain JN, Madan AK, Hiler ML, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;May 145(5):2273–2282.
   PubMed Web of Science ®Google Scholar
• Laforest S, Michaud A, Paris G, et al. Comparative analysis of three human adipocyte size measurement methods and their relevance for cardiometabolic risk. Obesity. Silver Spring 2017;Jan 25(1):122–131.
   PubMed Web of Science ®Google Scholar
• Deschênes D, Couture P, Dupont P, et al. Subdivision of the subcutaneous adipose tissue compartment and lipid-lipoprotein levels in women. Obes Res. 2003;Mar 11(3):469–476.
   PubMedGoogle Scholar
• Rodbell M. Metabolism of isolated fat cells. i. effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 1964;Feb 239 375–380.
   PubMed Web of Science ®Google Scholar
• Tchernof A, Desmeules A, Richard C, et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab. 2004;Jul 89(7):3425–3430.
   PubMed Web of Science ®Google Scholar
• Giusti V, Suter M, Verdumo C, et al. Molecular determinants of human adipose tissue: differences between visceral and subcutaneous compartments in obese women. J Clin Endocrinol Metab. 2004;Mar 89(3):1379–1384.
   PubMed Web of Science ®Google Scholar
• Adams M, Montague CT, Prins JB, et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest.1997 Dec 15 100(12)3149–3153.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;Jul 28(7):412–419.
   PubMed Web of Science ®Google Scholar